PMV Pharmaceuticals Announces Updated Promising Rezatapopt Monotherapy Interim Ovarian Cancer Data From PYNNACLE Phase 2 Pivotal Trial Life Science Investing
Exelixis Announces Update on Patent Litigation Trial Appeal with MSN Laboratories Life Science Investing
While Measles Cases Continue to Increase in The USA and Globally, NanoViricides is Getting Ready for Clinical Trials of Its Revolutionary Broad-spectrum Drug Candidate NV-387 as A Treatment for Measles Life Science Investing
Innventure Announces Board Leadership Changes to Further Enhance Board Independence and Acceleration of CEO Transition Life Science Investing
Chemomab Therapeutics to Present at H.C. Wainwright 28th Annual Global Investor Conference Life Science Investing
Palvella Therapeutics Completes Rolling Submission of New Drug Application to FDA for QTORIN Rapamycin for the Treatment of Microcystic Lymphatic Malformations Life Science Investing
Beam Therapeutics to Participate in Upcoming September 2026 Investor Conferences Life Science Investing
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026Â
